PROTEIN AND PEPTIDE LETTERS
Scope & Guideline
Illuminating the dynamic landscape of protein and peptide studies.
Introduction
Aims and Scopes
- Protein Structure and Function:
The journal publishes studies that explore the structural properties of proteins, their dynamics, and how these attributes relate to their biological functions. - Peptide Therapeutics and Drug Development:
Research on bioactive peptides, their mechanisms of action, and their potential applications in drug development and therapeutic interventions is a core focus. - Proteomics and Mass Spectrometry:
Innovative proteomic techniques, including mass spectrometry, are frequently featured, highlighting advancements in protein analysis and biomarker discovery. - Molecular Biology and Genetic Engineering:
The journal includes articles on the molecular mechanisms underlying gene expression, protein synthesis, and the use of genetic engineering techniques to modify proteins and peptides. - Biotechnology and Bioengineering Applications:
Studies that apply protein and peptide research to biotechnological processes, including enzyme engineering and the development of novel biomaterials, are emphasized. - Cancer Biology and Therapeutics:
There is a significant focus on the roles of proteins and peptides in cancer biology, including studies on oncogenic pathways and potential therapeutic targets. - Immunology and Vaccine Development:
Research related to the immunogenicity of proteins and peptides, including their use in vaccine development and immune response modulation, is also a key area of interest.
Trending and Emerging
- Protein-Protein Interactions and Networks:
There is a rising interest in studying protein-protein interactions and their implications in cellular networks, which is crucial for understanding complex biological processes. - Bioinformatics and Computational Biology:
The integration of bioinformatics tools to analyze protein structures, functions, and interactions is becoming more prevalent, facilitating deeper insights into protein science. - Peptide-Based Nanocarriers and Drug Delivery Systems:
Research on utilizing peptides as nanocarriers for drug delivery is on the rise, showcasing innovative approaches to enhance the bioavailability and efficacy of therapeutics. - Targeted Cancer Therapy:
A growing number of studies focus on the development of targeted therapies using engineered proteins and peptides, particularly in oncology, reflecting a shift towards personalized medicine. - Microbiome and Host Interactions:
Emerging research exploring the role of proteins and peptides in microbiome interactions and their effects on host health is gaining prominence, indicating a broader understanding of health and disease. - CRISPR and Gene Editing Technologies:
The applications of CRISPR and other gene-editing technologies in protein engineering and therapeutic development are increasingly being featured, highlighting their revolutionary impact on biotechnology.
Declining or Waning
- Traditional Enzymology:
Research focusing solely on classical enzymatic mechanisms without broader implications for protein engineering or therapeutic applications is waning, as interest shifts towards more applied and innovative approaches. - Basic Biochemical Pathways:
While foundational studies are essential, there is a noticeable decline in the publication of papers that exclusively describe basic metabolic pathways without integrating into larger biological or therapeutic contexts. - Agricultural Proteomics:
The application of proteomics specifically in agricultural settings, such as crop improvement, seems to be less emphasized in recent issues, indicating a shift towards more clinical and biomedical applications. - In Vitro Studies without Clinical Relevance:
Studies that focus solely on in vitro experiments without clear pathways to clinical application or relevance are becoming less common, as the journal seeks more translational research. - Historical Reviews on Protein Functions:
The journal appears to be moving away from historical reviews that do not incorporate current research trends or implications, favoring more forward-looking studies.
Similar Journals
Protein & Cell
Exploring the Frontiers of Protein and Cell ResearchProtein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.
Doklady Biochemistry and Biophysics
Advancing the Frontiers of Biochemical and Biophysical ResearchDoklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.
ACS Chemical Biology
Fostering Interdisciplinary Insights in Chemical BiologyACS Chemical Biology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of the chemical underpinnings of biological systems. With an ISSN of 1554-8929 and a distinguished track record since its inception in 2006, this journal provides a vital platform for the dissemination of high-quality research in the realms of biochemistry and molecular medicine, achieving a prestigious Q1 ranking in these categories as of 2023. In an era where interdisciplinary approaches are crucial, ACS Chemical Biology fosters collaboration among chemists and biologists, reflecting a steadfast commitment to exploring the chemical processes that govern life. Although it does not operate under an open-access model, the journal maintains a rigorous peer-review process, ensuring the publication of influential studies that shape the future of chemical biology. With an increasing impact factor and a focus on innovative research, ACS Chemical Biology remains an authoritative resource for researchers, professionals, and students eager to engage with cutting-edge findings in this dynamic field.
Peptide Science
Connecting researchers through groundbreaking peptide discoveries.Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.
Cell Chemical Biology
Exploring the Intersection of Chemistry and Biology.Cell Chemical Biology, published by Cell Press, stands at the forefront of interdisciplinary research in the realms of biochemistry, molecular biology, and pharmacology. With a robust impact factor evident in its prestigious Q1 quartile rankings across multiple categories including Clinical Biochemistry and Drug Discovery for 2023, this journal serves as a critical platform for disseminating cutting-edge scientific discoveries. As an Open Access publication, it ensures that vital research is accessible to a wide audience, fostering collaborations and driving innovation in the life sciences. Based in the United States, and featuring publications from 2016 to 2024, Cell Chemical Biology invites researchers, professionals, and students alike to contribute to its mission of advancing knowledge through rigorous peer-reviewed articles that address both fundamental and applied aspects of chemical biology.
PROTEOMICS
Shaping the future of life sciences through proteomic research.PROTEOMICS is a leading journal focused on the rapidly evolving field of proteomics, published by WILEY in Germany. With a solid reputation established since its inception in 2001, it has continually contributed to the understanding of protein functions and interactions within biological systems. As part of its commitment to academic excellence, PROTEOMICS is ranked in the second quartile for both Biochemistry and Molecular Biology categories (2023), reflecting its significant influence in advancing research in these areas. Although it does not currently provide open access options, it remains a vital resource for researchers, professionals, and students keen to explore innovative methodologies and findings in proteomic research. By publishing groundbreaking studies that bridge theoretical knowledge with practical applications, PROTEOMICS plays a crucial role in enhancing our understanding of molecular processes and driving forward advancements in the life sciences.
PROTEIN JOURNAL
Connecting Researchers to Protein BreakthroughsProtein Journal, published by Springer, stands as a significant academic resource in the fields of Analytical Chemistry, Biochemistry, Bioengineering, and Organic Chemistry. Since its inception in 1996, the journal has dedicated itself to the dissemination of high-quality research focused on protein chemistry and its biomedical applications. With an impressive impact reflected in its classification as a Q2 journal in Analytical Chemistry and Q3 in both Biochemistry and Bioengineering as of 2023, it provides an essential platform for researchers and practitioners to share their findings. The journal embraces the open-access model, enhancing accessibility to cutting-edge research. The Protein Journal is crucial for academicians, industry professionals, and students, catering to their need for rigorous scientific discourse and innovative discoveries in protein studies. With an established track record of converging over two decades of knowledge and research, it continues to influence and shape the advancements in this vital area of science.
BMC BIOTECHNOLOGY
Elevating Scientific Discourse in BiotechnologyBMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.
CURRENT PROTEIN & PEPTIDE SCIENCE
Bridging Knowledge Gaps in Protein and Peptide ScienceCURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
Bridging Molecular Biology and BioinformaticsPROTEINS - STRUCTURE FUNCTION AND BIOINFORMATICS, published by WILEY, is a leading journal in the fields of biochemistry, molecular biology, and structural biology, recognized for its significant contribution to protein research since its inception in 1986. With its impressive rankings in the Q1 category for Biochemistry and Q2 for both Molecular Biology and Structural Biology in 2023, the journal serves as an essential resource for researchers and professionals seeking to explore the intricate relationships between protein structures and their functions. The journal, based in the United States, operates without an Open Access model, ensuring a curated selection of high-quality peer-reviewed articles that drive innovation and collaboration in the scientific community. Engaging with the robust content of PROTEINS not only bolsters academic scholarship but also opens avenues for groundbreaking discoveries that are pivotal in the advancing field of bioinformatics.